GleamWall
中文EN

GIPL Global Innovative Platforms Inc.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1837774 · Fiscal year ends 09/30

Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-20.9%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-361.7%
Net margin-361.7%
FCF margin—
EBITDA margin—

Returns

ROE-190.0%
ROA-180.9%
ROIC (approx.)-395.6%
Asset turnover0.50x

Leverage & solvency

Liabilities / assets1.4%
Debt / equity0.00x
Current ratio34.73x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.50x
Accruals ratio-91.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-09-30FY20242024-09-30
Income statement
Revenue$0$0
R&D expense$382,832$23,376
SG&A expense$335,419$112,821
Operating income-$718,251-$136,197
Pretax income-$718,251-$136,197
Income tax—$0
Net income-$718,251-$136,197
EPS (basic)-0.02-0.01
EPS (diluted)-0.02-0.01
Weighted avg. shares (diluted)39.37M26.63M
Balance sheet
Cash & equivalents$17,828$15
Receivables$0—
Current assets$199,275$15
PP&E, net$0$0
Intangibles$0—
Total assets$199,275$15
Current liabilities$11,609$33,153
Short-term debt$1,500—
Total liabilities$11,609$33,153
Shareholders' equity$187,666-$33,138
Shares outstanding44.48M33.75M
Cash flow statement
Operating cash flow-$560,740-$87,378
Investing cash flow-$175,448$0
Financing cash flow$754,001$86,978

Free plan shows the latest 2 periods; Pro shows all 5 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.